We are live on ! Find out more
NTC

North Tide Capital Portfolio holdings

AUM $469M
1-Year Est. Return 6.57%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$651M
AUM Growth
+$65.7M
Cap. Flow
-$63.7M
Cap. Flow %
-9.79%
Top 10 Hldgs %
89.79%
Holding
20
New
5
Increased
3
Reduced
8
Closed
4

Top Buys

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$55.9M
2
PRGO icon
Perrigo
PRGO
+$45.6M
3
THC icon
Tenet Healthcare
THC
+$37.1M
4
GILD icon
Gilead Sciences
GILD
+$35.2M
5
IPXL
Impax Laboratories, Inc.
IPXL
+$12.1M

Top Sells

Rank Stock Value
1
SEM
Select Medical
SEM
+$57.9M
2
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$52.8M
3
KND
Kindred Healthcare
KND
+$33.4M
4
SVU
SUPERVALU Inc.
SVU
+$33.1M
5
LPNT
LifePoint Health, Inc.
LPNT
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 74.64%
2 Miscellaneous 19.43%
3 Consumer Staples 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLV icon
1
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$44.1B
$126M 19.43%
+1,700,000
New +$124M
SEM
2
DELISTED
Select Medical
SEM
$76.1M 11.7%
10,579,200
-7,980,800
-43% -$57.9M
TVTY
3
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$72.8M 11.18%
2,500,000
-2,000,000
-44% -$52.8M
GILD icon
4
Gilead Sciences
GILD
$187B
$67.9M 10.44%
1,000,000
+500,000
+100% +$35.2M
ENDP
5
DELISTED
Endo International plc
ENDP
$50.2M 7.72%
+4,500,000
New +$55.9M
PRGO icon
6
Perrigo
PRGO
$2.07B
$39.8M 6.12%
+600,000
New +$45.6M
VTRS icon
7
Viatris
VTRS
$19.4B
$39M 5.99%
1,000,000
+250,000
+33% +$10.1M
SVU
8
DELISTED
SUPERVALU Inc.
SVU
$38.6M 5.93%
1,428,571
-1,209,989
-46% -$33.1M
IPXL
9
DELISTED
Impax Laboratories, Inc.
IPXL
$38M 5.83%
3,000,000
+1,000,000
+50% +$12.1M
THC icon
10
Tenet Healthcare
THC
$21.3B
$35.4M 5.44%
+2,000,000
New +$37.1M
ELOS
11
DELISTED
Syneron Medical Ltd
ELOS
$31.6M 4.86%
3,000,000
-500,000
-14% -$4.84M
HZNP
12
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$10.2M 1.57%
+692,700
New +$11.2M
VVUS
13
DELISTED
Vivus Inc
VVUS
$10.1M 1.55%
900,930
-457,816
-34% -$5.18M
QHC
14
DELISTED
Quorum Health Corporation
QHC
$8.65M 1.33%
1,590,200
-909,800
-36% -$7.41M
OPCH icon
15
Option Care Health
OPCH
$3.63B
$5.1M 0.78%
750,000
-1,375,000
-65% -$9.09M
ARAY icon
16
Accuray
ARAY
$31.9M
$734K 0.11%
154,500
-845,500
-85% -$4.4M
MYGN icon
17
Myriad Genetics
MYGN
$305M
– –
-1,150,000
Closed -$19.2M
AGN
18
DELISTED
Allergan plc
AGN
– –
-100,000
Closed -$21M
KND
19
DELISTED
Kindred Healthcare
KND
– –
-4,250,000
Closed -$33.4M
LPNT
20
DELISTED
LifePoint Health, Inc.
LPNT
– –
-400,000
Closed -$22.7M

Similar funds

SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return
DG
Davidson & Garrard Lynchburg, Virginia $425M AUM 14.62% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
JWM
Jacobus Wealth Management Milwaukee, Wisconsin $382M AUM 16.31% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
MCL
MIK Capital LLC New York $344M AUM 26.72% 1-Year Est. Return
GIIO
Gen IV Investment Opportunities New York $269M AUM 21.06% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

North Tide Capital's Q1 2017 Portfolio in Review

As of Q1 2017, North Tide Capital held 20 positions worth $651M, up 11% from $585M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

North Tide Capital withdrew a net $63.7M in Q1 2017, closing 4 positions and reducing 8 holdings. Its most notable exit was Kindred Healthcare, an estimated $33.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 85% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, North Tide Capital opened a new position in Endo International plc worth $50.2M.

  • North Tide Capital's largest Q1 2017 buy was Endo International plc: 4,500,000 shares worth $50.2M.
  • North Tide Capital added most to Gilead Sciences in Q1 2017, an estimated $35.2M increase.
  • North Tide Capital's biggest Q1 2017 reduction was Select Medical, cutting an estimated $57.9M.
  • North Tide Capital fully exited Kindred Healthcare in Q1 2017, selling an estimated $33.4M.
  • North Tide Capital's ten largest holdings make up 90% of its $651M portfolio in Q1 2017.
  • North Tide Capital opened 5 new positions and closed 4 in Q1 2017.
  • North Tide Capital's portfolio value rose 11% quarter-over-quarter to $651M.

Based on North Tide Capital's 13F filing for Q1 2017, filed 15 May 2017.